Suppr超能文献

八旬老人的主动脉弓手术:是否合理?

Aortic arch surgery in octogenarians: is it justified?

作者信息

Kurazumi Hiroshi, Mikamo Akihito, Kudo Tomoaki, Suzuki Ryo, Takahashi Masaya, Shirasawa Bungo, Zempo Nobuya, Hamano Kimikazu

机构信息

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan.

Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan

出版信息

Eur J Cardiothorac Surg. 2014 Oct;46(4):672-7. doi: 10.1093/ejcts/ezu056. Epub 2014 Feb 28.

Abstract

OBJECTIVES

Elderly patients are sometimes denied aortic arch surgery because of the perception of poor outcomes and an unacceptable quality of life (QOL). In this study, we evaluated the early clinical outcomes, long-term survival and QOL following surgical treatment for aortic arch disease in octogenarian patients.

METHODS

A total of 47 consecutive patients over the age of 80 years were referred to our institutions. Of these patients, 20 underwent surgical intervention (surgical group) and 27 were treated medically (medical group). Kaplan-Meier survival analysis was performed between the two groups, and the results were compared with age-matched population data. The risk factors for mortality were determined using a Cox regression analysis. A QOL assessment was performed using the 36-item Short Form Health Survey.

RESULTS

The patient characteristics at baseline were not significantly different between the two groups. In the surgical cases, conventional total aortic arch replacement was performed in 15 patients, debranched thoracic endovascular aortic repair (TEVAR) in 2 and chimney TEVAR in 3. Emergency procedures were performed in 3 patients. No hospital deaths occurred in the surgical groups. Reoperation for bleeding was required in 2 patients, and prolonged mechanical ventilation was required in 4 patients. The 5-year survival was 61.5% in the surgical group and 14.2% in the medical group (P = 0.02). Freedom from aorta-related death at 5 years was 92.3% in the surgical group and 32.3% in the medical group (P = 0.01). There were no differences in the 5-year survival between patients undergoing surgical intervention and the sex- and age-matched population (P = 0.80), whereas the 5-year survival was significantly lower in patients who received medical therapy relative to the sex- and age-matched population (P < 0.001). Medical therapy was the sole risk factor for mortality (hazard ratio: 3.16, P = 0.04). Among the survivors at mid-term, the quality-of-life measures were similar between those in the surgical group and those in the medical group.

CONCLUSIONS

Surgical intervention for aortic arch disease in octogenarians can yield satisfactory early clinical outcomes and acceptable mid-term survival with adequate daily activity. This study indicates that among octogenarians, age alone should not disqualify a patient from receiving an aortic arch intervention.

摘要

目的

老年患者有时会因预期效果不佳和生活质量(QOL)不可接受而被拒绝接受主动脉弓手术。在本研究中,我们评估了八旬老人主动脉弓疾病手术治疗后的早期临床结果、长期生存率和生活质量。

方法

共有47例年龄超过80岁的连续患者被转诊至我们的机构。在这些患者中,20例接受了手术干预(手术组),27例接受了药物治疗(药物组)。对两组进行Kaplan-Meier生存分析,并将结果与年龄匹配的人群数据进行比较。使用Cox回归分析确定死亡的危险因素。使用36项简短健康调查问卷进行生活质量评估。

结果

两组患者的基线特征无显著差异。在手术病例中,15例患者接受了传统的全主动脉弓置换术,2例接受了去分支胸主动脉腔内修复术(TEVAR),3例接受了烟囱式TEVAR。3例患者接受了急诊手术。手术组无医院死亡病例。2例患者因出血需要再次手术,4例患者需要延长机械通气时间。手术组的5年生存率为61.5%,药物组为14.2%(P = 0.02)。手术组5年无主动脉相关死亡的生存率为92.3%,药物组为32.3%(P = 0.01)。接受手术干预的患者与性别和年龄匹配的人群之间的5年生存率无差异(P = 0.80),而接受药物治疗的患者相对于性别和年龄匹配的人群,5年生存率显著较低(P < 0.001)。药物治疗是死亡的唯一危险因素(风险比:3.16,P = 0.04)。在中期幸存者中,手术组和药物组的生活质量指标相似。

结论

八旬老人主动脉弓疾病的手术干预可以产生令人满意的早期临床结果,并在日常活动充足的情况下获得可接受的中期生存率。本研究表明,在八旬老人中,仅年龄不应使患者失去接受主动脉弓干预的资格。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验